Phase 1 KRAS P.G12C Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation

KRAS P.G12C

D3 Bio (Wuxi) Co., Ltd442 enrolled52 locationsNCT05410145

Recruiting

Phase 1Phase 2

Phase 1/2a Study of JAB-21822 Plus JAB-3312 in Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation

Non-small Cell Lung CancerKRAS P.G12C

Allist Pharmaceuticals, Inc.240 enrolled27 locationsNCT05288205